Decrease in heart rate following the administration of sugammadex in adults

BACKGROUND AND AIMS: Sugammadex is a novel agent for reversal of steroidal neuromuscular blocking agents (NMBAs) with potential advantages over acetylcholinesterase inhibitors. In preclinical trials, there have been rare instances of bradycardia with progression to cardiac arrest. To better define t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Trent, Peterson, Joshua, Hakim, Mohammed, Roth, Catherine, Tumin, Dmitry, Tobias, Joseph D., Hansen, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022043/
https://www.ncbi.nlm.nih.gov/pubmed/33840924
http://dx.doi.org/10.4103/joacp.JOACP_346_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022043/
https://www.ncbi.nlm.nih.gov/pubmed/33840924
http://dx.doi.org/10.4103/joacp.JOACP_346_19

Ejemplares similares